News | Nucs AI

Nucs AI Resources

Discover the latest news, research and publications driving advancements in prostate cancer treatment.

Nucs AI CEO and Co-Founder, Nijat Ahmadov, receiving the Cannes Neuron Award for Healthcare Innovation.

2 min read

Nucs AI Wins Cannes Neuron Award for Healthcare Innovation

Nucs AI, a leader in AI-driven radiology solutions, is proud to

announce that it has been awarded the prestigious Cannes

Neuron Award in the Healthcare category. This marks the first

time the Healthcare category has been included in the Cannes

Neuron Awards, making Nucs AI the inaugural winner. This

recognition underscores Nucs AI's pioneering advancements in

artificial intelligence for medical imaging, transforming

diagnostics and workflow efficiency in radiology while enhancing

patient care, saving lives, and reducing costs.

‍

Female radiology technician in a blue medical uniform operating advanced imaging equipment and analyzing PSMA-PET/CT scan results on a computer screen, aiding in prostate cancer diagnosis and management.

2 min read

Nucs AI closes $3.5 million in seed funding round

Medtech startup Nucs AI has raised $3.5 million Seed funding. Founded in 2023 in Berlin and headquartered in San Francisco, Nucs AI uses precision medicine to diagnose and treat prostate cancer.

Contact us today

Take the next step to discover how Nucs AI can transform your clinical management of prostate cancer care.